Rational development of multicomponent mRNA vaccine candidates against mpox

Rational development of multicomponent mRNA vaccine candidates against mpox

The re-emerging mpox (formerly monkeypox) virus (MPXV), a member of Orthopoxvirus genus together with variola virus (VARV) and vaccinia virus (VACV), has led to public health emergency of international concern since July 2022. Inspired by the unprecedent success of coronavirus disease 2019 (COVID-19...

Full description

Bibliographic Details
Main Authors: Rong-Rong Zhang, Zheng-Jian Wang, Yi-Long Zhu, Wei Tang, Chao Zhou, Suo-Qun Zhao, Mei Wu, Tao Ming, Yong-Qiang Deng, Qi Chen, Ning-Yi Jin, Qing Ye, Xiao Li, Cheng-Feng Qin
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Emerging Microbes and Infections
Subjects:
Mpox virus
mRNA vaccine
protective antigen
multicomponent
mouse model
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2023.2192815

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2023.2192815

Similar Items